IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.27
+8.65%0
Insider buys (3m)
7
Insider sells (3m)
-$3.1M
Net value (3m)
+11.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 27, 2026 | SCHACHLE JOSEPH K · officer: Chief Operating Officer | Sale | 4,767 | $3.56 |
| Oct 27, 2026 | Magrath George · director, officer: Chief Executive Officer | Sale | 9,591 | $3.58 |
| Oct 27, 2026 | Gagnon Robert E. · officer: Chief Financial Officer | Sale | 14,000 | $3.55 |
| Oct 27, 2026 | YERXA BENJAMIN R · director, officer: President | Sale | 25,520 | $3.53 |
| Oct 27, 2026 | YERXA BENJAMIN R · director, officer: President | Sale | 7,669 | $3.55 |
| Oct 2, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund · director, other: See Remarks | Sale | 556,000 | $4.96 |
| Sep 11, 2026 | Magrath George · director, officer: Chief Executive Officer | F-InKind | 75,541 | $5.97 |
| Sep 11, 2026 | Magrath George · director, officer: Chief Executive Officer | M-Exempt | 392,157 | $1.15 |
| Sep 8, 2026 | Gallagher Cam · director | M-Exempt | 784,314 | $1.15 |
| Sep 8, 2026 | Gagnon Robert E. · officer: Chief Financial Officer | Sale | 28,000 | $4.54 |
| Jul 27, 2026 | Magrath George · director, officer: Chief Executive Officer | Sale | 9,475 | $2.95 |
| Jul 27, 2026 | YERXA BENJAMIN R · director, officer: President | Sale | 7,429 | $2.97 |
| Jul 27, 2026 | Gagnon Robert E. · officer: Chief Financial Officer | Sale | 7,783 | $2.95 |
| Jul 27, 2026 | SCHACHLE JOSEPH K · officer: Chief Operating Officer | Sale | 4,644 | $2.94 |
| May 20, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund · director, other: See Remarks | Sale | 1,700,000 | $4.35 |
| Apr 27, 2026 | Magrath George · director, officer: Chief Executive Officer | Sale | 9,511 | $5.22 |
| Apr 27, 2026 | Gagnon Robert E. · officer: Chief Financial Officer | Sale | 7,842 | $5.18 |
| Apr 27, 2026 | YERXA BENJAMIN R · director, officer: President | Sale | 7,470 | $5.24 |
| Apr 27, 2026 | SCHACHLE JOSEPH K · officer: Chief Operating Officer | Sale | 4,697 | $5.22 |
| Apr 27, 2026 | Zaremba Rabourn Amy · officer: Head of Fin. Quality Assurance | Sale | 1,641 | $5.20 |
| Apr 27, 2026 | Jayagopal Ashwath · officer: Chief Scientific & Dev. Ofc. | Sale | 7,542 | $5.19 |
| Apr 22, 2026 | Benton Susan · director | A-Award | 24,367 | $0.00 |
| Apr 22, 2026 | Ainsworth Sean · director | A-Award | 24,367 | $0.00 |
| Apr 22, 2026 | Bennett Jean · director | A-Award | 24,367 | $0.00 |
| Apr 22, 2026 | Gallagher Cam · director | A-Award | 24,367 | $0.00 |
| Apr 22, 2026 | Graves Adrienne L · director | A-Award | 24,367 | $0.00 |
| Apr 22, 2026 | MANUSO JAMES S J · director | A-Award | 24,367 | $0.00 |
| Apr 22, 2026 | Rodgers Richard J · director | A-Award | 24,367 | $0.00 |
| Mar 18, 2026 | Jayagopal Ashwath · officer: Chief Scientific & Dev. Ofc. | Sale | 3,719 | $5.12 |
| Mar 18, 2026 | SCHACHLE JOSEPH K · officer: Chief Operating Officer | Sale | 3,719 | $5.25 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 27, 2026